Evidence map›Paper›PMID 40399254›Full record

ArticleBlood cancer journal2025

Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1.

Warren Fiskus, Christopher P Mill, Christine Birdwell, John A Davis, Kaberi Das, Steffen Boettcher, Tapan M Kadia, Courtney D DiNardo, Koichi Takahashi, Sanam Loghavi and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Warren FiskusThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-7343-6214
Christopher P MillThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-0957-6009
Christine BirdwellThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
John A DavisThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kaberi DasThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Steffen BoettcherUniversity of Zurich and University Hospital Zurich, CH-8091, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9937-0957
Tapan M KadiaThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-9892-9832
Courtney D DiNardoThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9003-0390
Koichi TakahashiThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8027-9659
Sanam LoghaviThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-8980-3202
Michael J SothThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tim HeffernanThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gerard M McGeehanSyndax Pharmaceuticals, Waltham, MA, USA.
Xinjia RuanThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xiaoping SuThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Christopher R VakocCold Spring Harbor Laboratory, Cold Spring Harbor, NY, 11724, USA.
Naval DaverThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-7103-373X
Kapil N BhallaThe University of Texas MD Anderson Cancer Center, Houston, TX, USA. kbhalla@mdanderson.org.ORCID http://orcid.org/0000-0001-5209-5126

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40399254
PMCPMC12095577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.